Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells
Open Access
- 3 August 2009
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 119 (8), 2343-2358
- https://doi.org/10.1172/jci37205
Abstract
The active vitamin D metabolite 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3] has wide but not fully understood antitumor activity. A previous transcriptomic analysis of 1α,25(OH)2D3 action on human colon cancer cells revealed cystatin D (CST5), which encodes an inhibitor of several cysteine proteases of the cathepsin family, as a candidate target gene. Here we report that 1α,25(OH)2D3 induced vitamin D receptor (VDR) binding to, and activation of, the CST5 promoter and increased CST5 RNA and protein levels in human colon cancer cells. In cells lacking endogenous cystatin D, ectopic cystatin D expression inhibited both proliferation in vitro and xenograft tumor growth in vivo. Furthermore, cystatin D inhibited migration and anchorage-independent growth, antagonized the Wnt/β-catenin signaling pathway, and repressed c-MYC expression. Cystatin D repressed expression of the epithelial-mesenchymal transition inducers SNAI1, SNAI2, ZEB1, and ZEB2 and, conversely, induced E-cadherin and other adhesion proteins. CST5 knockdown using shRNA abrogated the antiproliferative effect of 1α,25(OH)2D3, attenuated E-cadherin expression, and increased c-MYC expression. In human colorectal tumors, expression of cystatin D correlated with expression of VDR and E-cadherin, and loss of cystatin D correlated with poor tumor differentiation. Based on these data, we propose that CST5 has tumor suppressor activity that may contribute to the antitumoral action of 1α,25(OH)2D3 in colon cancer.Keywords
This publication has 52 references indexed in Scilit:
- Genomic and Proteomic Analysis Reveals a Threshold Level of MYC Required for Tumor MaintenanceCancer Research, 2008
- Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal CancerJournal of Clinical Oncology, 2008
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional PathwaysCancer Research, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2Cancer and Metastasis Reviews, 2007
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007
- Frequent epigenetic inactivation of cystatin M in breast carcinomaOncogene, 2006
- Do sunlight and vitamin D reduce the likelihood of colon cancer?International Journal of Epidemiology, 2005
- Multiple Roles for Cysteine Cathepsins in CancerCell Cycle, 2004
- Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cellsOncogene, 2003